BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9305719)

  • 1. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
    Lawrence W; Anderson JR; Gehan EA; Maurer H
    Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.
    Metts J; Xue W; Gao Z; Oberoi S; Weiss AR; Venkatramani R; Harrison DJ
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31009. PubMed ID: 38627882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.
    Walterhouse DO; Barkauskas DA; Hall D; Ferrari A; De Salvo GL; Koscielniak E; Stevens MCG; Martelli H; Seitz G; Rodeberg DA; Shnorhavorian M; Dasgupta R; Breneman JC; Anderson JR; Bergeron C; Bisogno G; Meyer WH; Hawkins DS; Minard-Colin V
    J Clin Oncol; 2018 Oct; 36(35):JCO2018789388. PubMed ID: 30351998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
    Dar MS; Bég SA
    Diabetes Metab Syndr Obes; 2018; 11():845-853. PubMed ID: 30568472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
    Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
    Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current topics and management of head and neck sarcomas.
    Kobayashi K; Hanai N; Yoshimoto S; Saito Y; Homma A
    Jpn J Clin Oncol; 2023 Aug; 53(9):743-756. PubMed ID: 37309253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.
    Metts J; Xue W; Gao Z; Ermoian R; Bradley JA; Arnold MA; Dasgupta R; Venkatramani R; Walterhouse D
    Cancer; 2023 Jun; 129(11):1735-1743. PubMed ID: 36857314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle beam radiation therapy for head and neck rhabdomyosarcoma in adults.
    Yang J; Gao J; Hu J; Hu W; Qiu X; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1191. PubMed ID: 36544680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of pediatric extragonadal pelvic soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
    Pace E; Johnson TS; Kao SC; Parikh AK; Qi J; Rajderkar DA; Reid JR; Towbin AJ; States LJ
    Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29966. PubMed ID: 36482882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
    Lo WL; Huang WH; Yeh CF
    In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
    Camero S; Cassandri M; Pomella S; Milazzo L; Vulcano F; Porrazzo A; Barillari G; Marchese C; Codenotti S; Tomaciello M; Rota R; Fanzani A; Megiorni F; Marampon F
    Front Oncol; 2022; 12():1016894. PubMed ID: 36248991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior Clinical Outcomes of Pediatric Rhabdomyosarcoma in Thailand: A 16-Year Experience in a Single Tertiary Institution.
    Preechawetchakul P; Sripornsawan P; Rajborirug S; Sangkhathat S; Sangsupavanich P; Chotsampancharoen T
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2805-2811. PubMed ID: 36037137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cell Markers in Rhabdomyosarcoma in Children.
    Radzikowska J; Czarnecka AM; Klepacka T; Rychłowska-Pruszyńska M; Raciborska A; Dembowska-Bagińska B; Pronicki M; Kukwa A; Fendler W; Smyczyńska U; Kukwa W; Krzeski A
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
    Crane JN; Xue W; Qumseya A; Gao Z; Arndt CAS; Donaldson SS; Harrison DJ; Hawkins DS; Linardic CM; Mascarenhas L; Meyer WH; Rodeberg DA; Rudzinski ER; Shulkin BL; Walterhouse DO; Venkatramani R; Weiss AR
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29644. PubMed ID: 35253352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French Experience.
    Machavoine R; Helfre S; Bernier V; Bolle S; Leseur J; Corradini N; Rome A; Defachelles AS; Deneuve S; Bernard S; Fayoux P; Nicollas R; Mondain M; Luscan R; Denoyelle F; Simon F; Kadlub N; Kolb F; Honart JF; Orbach D; Minard-Colin V; Moya-Plana A; Couloigner V
    Front Pediatr; 2021; 9():783754. PubMed ID: 35186818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.
    Gallego S; Bernabeu D; Garrido-Pontnou M; Guillen G; Hindi N; Juan-Ribelles A; Márquez C; Mata C; Orcajo J; Ramírez G; Ramos M; Romagosa C; Ruano D; Rubio P; Vergés R; Valverde C;
    Clin Transl Oncol; 2021 Dec; 23(12):2460-2473. PubMed ID: 34212338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with
    Colletti M; Galardi A; Miele E; Di Paolo V; Russo I; De Stefanis C; De Vito R; Rinelli M; Ciolfi A; De Angelis B; Zin A; Guffanti A; Digilio MC; Novelli A; Alaggio R; Milano GM; Di Giannatale A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067464
    [No Abstract]   [Full Text] [Related]  

  • 18. Endoglin Expression and Microvessel Density as Prognostic Factors in Pediatric Rhabdomyosarcoma.
    Radzikowska J; Krzeski A; Czarnecka AM; Klepacka T; Rychlowska-Pruszynska M; Raciborska A; Dembowska-Baginska B; Pronicki M; Kukwa A; Sierdzinski J; Kukwa W
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
    Ashley CW; Da Cruz Paula A; Ferrando L; Gularte-Mérida R; Sebastiao APM; Brown DN; Gazzo AM; Pareja F; Stylianou A; Abu-Rustum NR; Reis-Filho JS; Buehler D; Weisman P; Chiang S; Weigelt B
    Histopathology; 2021 Aug; 79(2):176-186. PubMed ID: 33527450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.